HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
CI-1033
Description
CI-1033 is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. CI-1033 treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
No brand information found.
